title: Induction therapy for thymic malignancies.
abstract: Thymic malignancies are rare tumors of the chest that express a broad range of biological behaviors. Surgery remains the mainstay of therapy, and complete surgical resection is the primary predictor of long-term survival. Although there is a paucity of clinical trials assessing the role of induction/adjuvant chemotherapy and/or radiation therapy in the treatment of thymic malignancies, existing data suggest that induction therapy should be offered for the treatment of advanced-stage disease, and postoperative radiation for specific stages.
authors: Division of Thoracic Surgery, The Johns Hopkins Medical Institutions, 600 North Wolfe Street, Blalock 240, Baltimore, MD 21287, USA.
authors: Avedis
authors: A
authors: Meneshian
authors: Stephen C
authors: SC
authors: Yang
mesh_terms: D003131:Combined Modality Therapy; D006801:Humans; D009367:Neoplasm Staging; D013953:Thymus Neoplasms / Q000473:pathology / Q000628:therapy*; D016896:Treatment Outcome